Carboxyamidotriazole ameliorates experimental colitis by inhibition of cytokine production, nuclear factor-κB activation, and colonic fibrosis.
J Pharmacol Exp Ther
; 342(2): 356-65, 2012 Aug.
Article
in En
| MEDLINE
| ID: mdl-22553216
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Triazoles
/
NF-kappa B
/
Colitis
/
Colon
Language:
En
Journal:
J Pharmacol Exp Ther
Year:
2012
Document type:
Article